Clinical Trial Update: Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (AEGIS-2) [Phase 3]

View source ↗

Summary

Phase 3 trial update for an oral ferric iron formulation in quiescent Crohn's disease shows safety and efficacy data for iron deficiency anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease
• Iron Deficiency Anemia

Drugs mentioned

• Oral ferric iron formulation

Snippet

Sponsor: Shield Therapeutics | Conditions: Iron Deficiency Anaemia, Inflammatory Bowel Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-10-27